Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Medtronic
Baxter
Boehringer Ingelheim
Johnson and Johnson

Last Updated: January 20, 2020

DrugPatentWatch Database Preview

Acs Dobfar Spa Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for ACS DOBFAR SPA, and what generic and branded alternatives to ACS DOBFAR SPA drugs are available?

ACS DOBFAR SPA has nine approved drugs.



Summary for Acs Dobfar Spa
US Patents:0
Tradenames:6
Ingredients:6
NDAs:9
Drug Master File Entries: 84

Drugs and US Patents for Acs Dobfar Spa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acs Dobfar Spa MEROPENEM meropenem INJECTABLE;INJECTION 204139-002 Jun 9, 2016 AP RX No No   Start Trial   Start Trial
Acs Dobfar Spa CEFUROXIME SODIUM cefuroxime sodium INJECTABLE;INJECTION 064125-002 May 30, 1997 AP RX No No   Start Trial   Start Trial
Acs Dobfar Spa AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 090889-001 Apr 3, 2013 AP RX No No   Start Trial   Start Trial
Acs Dobfar Spa PENICILLIN G POTASSIUM penicillin g potassium INJECTABLE;INJECTION 205043-002 Oct 26, 2018 AP RX No No   Start Trial   Start Trial
Acs Dobfar Spa CEFUROXIME SODIUM cefuroxime sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 064125-001 May 30, 1997 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Merck
Johnson and Johnson
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.